SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-24-106381
Filing Date
2024-09-13
Accepted
2024-09-13 16:26:30
Documents
5
Period of Report
2024-09-13

Document Format Files

Seq Description Document Type Size
1 PRE 14A 2024_pyxs-special_mtg_pr.htm PRE 14A 826070
2 GRAPHIC img26993073_0.jpg GRAPHIC 29935
3 GRAPHIC img26993073_1.jpg GRAPHIC 41024
4 GRAPHIC img26993073_2.jpg GRAPHIC 163677
5 GRAPHIC img26993073_3.jpg GRAPHIC 83386
  Complete submission text file 0000950170-24-106381.txt   1265581
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40881 | Film No.: 241298103
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)